Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes (Q57259837)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mika Kähönen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Markus Perola

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

A Pietilä

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

T Zeller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

L Moilanen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

M S Nieminen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Y A Kesäniemi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

S Blankenberg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A Jula

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

V Salomaa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Health 2000 and FINRISK97 Studies

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

1 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

Journal of Internal Medicine

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

269

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

322-332

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

Inflammation and metabolic disorders

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

An immune origin of type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Immunological and inflammatory functions of the interleukin-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

A genome-wide association study identifies protein quantitative trait loci (pQTLs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Thirty-five-year trends in cardiovascular risk factors in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

The structure of haplotype blocks in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

A comparison of bayesian methods for haplotype reconstruction from population genotype data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Thirty-one novel biomarkers as predictors for clinically incident diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Metabolic syndrome and incident diabetes: current state of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02294.X

10.1111/J.1365-2796.2010.02294.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21205020%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference